Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Phase III clinical investigation

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

David R. Strayer, William A. Carter, [ ... ], William M. Mitchell

The impact of the COVID-19 pandemic on scientific research in the life sciences

Massimo Riccaboni, Luca Verginer

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

Miranta Antoniou, Andrea L Jorgensen, Ruwanthi Kolamunnage-Dona

Stock Market Returns and Clinical Trial Results of Investigational Compounds: An Event Study Analysis of Large Biopharmaceutical Companies

Thomas J. Hwang

How Frequently Do the Results from Completed US Clinical Trials Enter the Public Domain? - A Statistical Analysis of the ClinicalTrials.gov Database

Hiroki Saito, Christopher J. Gill

The Value of Source Data Verification in a Cancer Clinical Trial

Catrin Tudur Smith, Deborah D. Stocken, [ ... ], John P. Neoptolemos

Dose-Finding Based on Bivariate Efficacy-Toxicity Outcome Using Archimedean Copula

Yuxi Tao, Junlin Liu, [ ... ], Fangrong Yan

Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results

Pilar Suñé, Josep Maria Suñé, J. Bruno Montoro

Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial

Elliot Marseille, Jennifer M. Mitchell, James G. Kahn

Review of the Reporting of Survival Analyses within Randomised Controlled Trials and the Implications for Meta-Analysis

Sarah Batson, Gemma Greenall, Pollyanna Hudson

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol

Georg Griesinger, Pierre J. M. Verweij, [ ... ], Basil C. Tarlatzis

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

Satoshi Motoya, Kenji Watanabe, [ ... ], Toshifumi Hibi

Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

David R. Strayer, Diane Young, William M. Mitchell

Tweets by @plosone

Advertisement

Create a weekly email alert for: Phase III clinical investigation

You can change these options by clicking profile then "Alerts and Notifications"